Same

12 research sources Also known as: s-adenosyl methionine s-adenosyl-l-methionine ademetionine
94 Products on Market
200.0 mg Median Dose
🟢 100/100 Market Safety Score
12 Research Sources
Browse 94 products →

Top-Rated Same Products

View all Same products → Best Same rankings →

Evidence Summary

SAMe is a naturally occurring compound investigated primarily for its roles in mental health and liver function. Research suggests it may be effective as an adjuvant treatment for depression and may support liver health in chronic or alcoholic liver disease.

Evidence by Condition

Depression Moderate

SAMe is studied as an effective adjuvant therapy and standalone treatment for adults with depression.

Liver Disease Moderate

Evidence suggests potential benefits for chronic and alcoholic liver disease, including impacts on hepatic glutathione levels.

Effective Doses

Not specified in the provided research.

Key Findings

  • SAMe serves as an effective adjuvant therapy for patients with depression (PMID: 38199136)
  • Meta-analyses support the use of SAMe for depression in adults (PMID: 27727432)
  • Oral SAMe may affect hepatic glutathione levels in patients with liver disease (PMID: 2781235)

Limitations

Some high-level Cochrane reviews on alcoholic liver disease have been withdrawn, and much of the research focuses on specific subsets of liver disease.

Safety & Interactions

No specific interactions or contraindications were provided in the source text.

AI-generated summary from 12 peer-reviewed studies. Not medical advice. Always consult a healthcare provider.

Drug-Supplement Interactions

Ssri 🟡 Moderate
Mechanism: SAMe may enhance serotonin synthesis and signaling; combined with SSRIs may increase serotonin levels excessively.
Effect: Possible serotonin syndrome
Management: Avoid combination. If used together, monitor closely for serotonin syndrome.
Evidence: probable
Mechanism: SAMe may enhance antidepressant effect of tricyclics, potentially causing excessive serotonergic/noradrenergic activity.
Effect: Possible serotonin syndrome or excessive antidepressant effect
Management: Monitor closely. May allow lower tricyclic doses under medical supervision.
Evidence: probable

⚠️ This information is for educational purposes only and does not constitute medical advice. Always consult your healthcare provider before combining supplements with medications.

Claims vs. Evidence

100% Evidence-Backed
0% Unsupported
83% Structure/Function
Claim Type% of ProductsEvidence RequiredStatus
All Other 100% Tier D (Unclassified) ✅ Supported
Structure/Function 83% Tier C (DSHEA Structure/Function (no pre-approval)) ✅ Supported
Nutrient 6% Tier D (Unknown) ✅ Supported

Research by Topic

Research Evidence (12)

Meta Analysis: 8 Systematic Review: 3 Rct: 1
B S-adenosyl-L-methionine for alcoholic liver diseases
Meta Analysis The Cochrane database of systematic reviews 2006 n=434

**Rambaldi et al., 2006** | Cochrane Database Syst Rev | Meta Analysis Rambaldi A, Gluud C. S-adenosyl-L-methionine for alcoholic liver diseases. Cochrane Database Syst Rev. 2006-Apr-19(2):CD002235 BACKGROUND: Alcohol is a major cause of liver diseas...

B S-adenosyl methionine (SAMe) for depression in adults
Meta Analysis The Cochrane database of systematic reviews 2016 n=934

**Galizia et al., 2016** | Cochrane Database Syst Rev | Meta Analysis Galizia Ilaria, Oldani Lucio, ... Young Allan H. S-adenosyl methionine (SAMe) for depression in adults. Cochrane Database Syst Rev. 2016-Oct-10;10(10):CD011286 BACKGROUND: Depressi...

B Systemic juvenile idiopathic arthritis and adult-onset Still's disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR/PReS recommendations for the diagnosis and management of Still's disease
Meta Analysis Annals of the rheumatic diseases 2024 n=1010

**De et al., 2024** | Ann Rheum Dis | Meta Analysis De Matteis Arianna, Bindoli Sara, ... Mitrovic Stéphane. Systemic juvenile idiopathic arthritis and adult-onset Still's disease are the same disease: evidence from systematic reviews and meta-analys...

B SAMe-TT2R2 Score to Predict Time in Therapeutic Range of Vitamin K Antagonists in Asian and Non-Asian patients: A Systematic Review and Meta-analysis
Meta Analysis American journal of cardiovascular drugs : drugs, devices, and other interventions 2024 n=36690

**Poonchuay et al., 2024** | Am J Cardiovasc Drugs | Meta Analysis Poonchuay Natnicha, Saokaew Surasak, Incomenoy Supatcha. SAMe-TT2R2 Score to Predict Time in Therapeutic Range of Vitamin K Antagonists in Asian and Non-Asian patients: A Systematic R...

B S-Adenosylmethionine (SAMe) as an adjuvant therapy for patients with depression: An updated systematic review and meta-analysis
Meta Analysis General hospital psychiatry 2024 n=1522

**Peng et al., 2024** | Gen Hosp Psychiatry | Meta Analysis Peng Tzu-Rong, Cheng Han-Yu, Wu Ta-Wei. S-Adenosylmethionine (SAMe) as an adjuvant therapy for patients with depression: An updated systematic review and meta-analysis. Gen Hosp Psychiatry. ...

B S-adenosyl-L-methionine for alcoholic liver diseases
Systematic Review The Cochrane database of systematic reviews 2001 n=330

**Rambaldi et al., 2001** | Cochrane Database Syst Rev | Systematic Review Rambaldi A, Gluud C. S-adenosyl-L-methionine for alcoholic liver diseases. Cochrane Database Syst Rev. 2001(4):CD002235 BACKGROUND: Alcohol is a major cause of liver disease i...

B WITHDRAWN: S-adenosyl-L-methionine for alcoholic liver diseases
Meta Analysis The Cochrane database of systematic reviews 2015

**Rambaldi et al., 2015** | Cochrane Database Syst Rev | Meta Analysis Rambaldi Andrea, Gluud Christian. WITHDRAWN: S-adenosyl-L-methionine for alcoholic liver diseases. Cochrane Database Syst Rev. 2015-Nov-11;2015(11):CD002235. doi:10.1002/14651858....

C S-adenosyl-L-methionine for the treatment of chronic liver disease: a systematic review and meta-analysis
Meta Analysis PloS one 2015 n=705

**Guo et al., 2015** | PLoS One | Meta Analysis Guo Tao, Chang Lei, ... Liu Quanyan. S-adenosyl-L-methionine for the treatment of chronic liver disease: a systematic review and meta-analysis. PLoS One. 2015;10(3):e0122124. doi:10.1371/journal.pone.01...

C S-Adenosylmethionine (SAMe) for Liver Health: A Systematic Review
Systematic Review Nutrients 2024 n=15

**Baden et al., 2024** | Nutrients | Systematic Review Baden Kyrie Eleyson R, McClain Halley, ... Chen Aleda M H. S-Adenosylmethionine (SAMe) for Liver Health: A Systematic Review. Nutrients. 2024-Oct-28;16(21). doi:10.3390/nu16213668 BACKGROUND/OBJE...

C SAMe-TT2R2 to Predict Clinical Outcomes and Time in Therapeutic Range in Patients on Vitamin K Antagonists: A Systematic Review and Meta-Analysis
Meta Analysis The Annals of pharmacotherapy 2024 n=22

**Incomenoy et al., 2024** | Ann Pharmacother | Meta Analysis Incomenoy Supatcha, Saokaew Surasak, Poonchuay Natnicha. SAMe-TT2R2 to Predict Clinical Outcomes and Time in Therapeutic Range in Patients on Vitamin K Antagonists: A Systematic Review and...

C S-adenosylmethionine (SAMe) as treatment for depression: a systematic review
Systematic Review Clinical and investigative medicine. Medecine clinique et experimentale 2005

**Williams et al., 2005** | Clin Invest Med | Systematic Review Williams Anna-leila, Girard Christine, ... Katz David L. S-adenosylmethionine (SAMe) as treatment for depression: a systematic review. Clin Invest Med. 2005-Jun;28(3):132-9 PURPOSE: To a...

D Effects of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease
Rct Scandinavian journal of gastroenterology 1989 n=9

**Vendemiale et al., 1989** | Scand J Gastroenterol | Rct Vendemiale G, Altomare E, ... Albano O. Effects of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease. Scand J Gastroenterol. 1989-May;24(4):407-15 S-Adenosyl-L...

Related Supplements

Frequently Asked Questions

What is SAMe and what is it used for?

SAMe is a naturally occurring compound found in the body. There is moderate evidence suggesting it may be used to support liver health and mental health.

Does SAMe work for depression?

Yes, there is moderate evidence that SAMe can be an effective standalone treatment or an added therapy for adults with depression. Research supports its use as an effective adjuvant therapy.

Can SAMe help with liver disease?

There is moderate evidence that SAMe may benefit people with chronic or alcoholic liver disease. It may work by affecting hepatic glutathione levels in the liver.

What is the effective dose of SAMe?

The provided research does not specify an effective or recommended dose for SAMe. You should consult a healthcare professional to determine an appropriate dosage for your needs.

Are there any drug interactions with SAMe?

There are currently no documented drug interactions for SAMe in the available research. However, you should always consult your doctor before starting a new supplement if you are taking medication.

Is SAMe safe to take?

No specific safety concerns or contraindications were identified in the provided research. As with any supplement, it is important to discuss use with a medical professional.

Who should avoid taking SAMe?

The available research does not list specific groups of people who should avoid SAMe. You should speak with a doctor to ensure it is safe for your specific health profile.

Answers generated from research evidence. Not medical advice.